Please wait while the formulary information is being retrieved.
LATISSE (BIMATOPROST)
- Hypotrichosis of eyelid lashes
0.03 % eyelash drops
- Apply 1 drop to applicator and apply to upper eyelid, along eyelashes, by topical route once daily at nighttime
0.03 % drops with applicator, eyelash base
- Apply 1 drop to applicator and apply to upper eyelid, along eyelashes, by topical route once daily at nighttime
Hypotrichosis of eyelid lashes
- Apply 1 drop to applicator and apply to upper eyelid, along eyelashes, by topical route once daily at nighttime
- None
Contraindicated
- None
Severe
Moderate
- bimatoprost
- latanoprost
- Lumigan
- Rescula
- tafluprost (PF)
- Travatan Z
- travoprost
- travoprost (benzalkonium)
- unoprostone isopropyl
- Xalatan
- Zioptan (pf)
- None
Contraindicated
- Cystoid macular edema
- Macular retinal edema
Severe
Moderate
- Aphakia
- Iritis
- Pseudophakia
- Uveitis
LATISSE (BIMATOPROST)
- Hypotrichosis of eyelid lashes
- None
- Conjunctival hyperemia
- Dry eye
- Hirsutism
- Hyperpigmentation of eyelid
- Hypertrichosis of eyelid eyelashes
- Ocular irritation
- Ocular itching
More Frequent
Severe
Less Severe
- Blepharitis
- Cataracts
- Eyelid erythema
- Infection
- Ocular pain
- Punctate keratitis
- Visual changes
- Blurred vision
- Foreign body sensation of eye
- Headache disorder
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Abnormal hepatic function tests
- Allergic conjunctivitis
- Bacterial keratitis
- Chemosis
- Cystoid macular edema
- General weakness
- Hypersensitivity drug reaction
- Hypertension
- Iris hyperpigmentation
- Iritis
- Ocular inflammation
Less Severe
- Asthenopia
- Dizziness
- Eye tearing
- Eyelid edema
- Hypotrichosis of eyelid lashes
- Nausea
- Ocular discharge
- Periorbital edema
- Photophobia
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Bimatoprost (Topical)
Risk of permanent iris hyperpigmentation.
- 1 Day – 18 Years
- Risk of permanent iris hyperpigmentation.
Bimatoprost
- Severity Level:
2
- Additional Notes: Insufficient human data available
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Bimatoprost
Insufficient data available
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient data available |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Hypotrichosis of eyelid lashes | |
| H02.72 | Madarosis of eyelid and periocular area |
| H02.721 | Madarosis of right upper eyelid and periocular area |
| H02.722 | Madarosis of right lower eyelid and periocular area |
| H02.723 | Madarosis of right eye, unspecified eyelid and periocular area |
| H02.724 | Madarosis of left upper eyelid and periocular area |
| H02.725 | Madarosis of left lower eyelid and periocular area |
| H02.726 | Madarosis of left eye, unspecified eyelid and periocular area |
| H02.729 | Madarosis of unspecified eye, unspecified eyelid and periocular area |
| 0-9 | A-Z |
|---|---|
| H02.72 | Madarosis of eyelid and periocular area |
| H02.721 | Madarosis of right upper eyelid and periocular area |
| H02.722 | Madarosis of right lower eyelid and periocular area |
| H02.723 | Madarosis of right eye, unspecified eyelid and periocular area |
| H02.724 | Madarosis of left upper eyelid and periocular area |
| H02.725 | Madarosis of left lower eyelid and periocular area |
| H02.726 | Madarosis of left eye, unspecified eyelid and periocular area |
| H02.729 | Madarosis of unspecified eye, unspecified eyelid and periocular area |
Formulary Reference Tool